| Title: | Genetics of colorectal, endometrial and other cancers |
| Lead Institution: | University of Oxford |
| Principal investigator: |
Application 155012
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
About
The risk of cancer is partly determined by inherited factors (genetic variants). By identifying these genetic variants, we can identify groups of people who are an enhanced risk of cancer and, where possible, offer them measures to reduce that risk. Some of the genetic variants may have a major effect (e.g. ten-fold increased risk), whereas others may only affect risk by about 10%. Nevertheless, as many genetic variants are expected to influence cancer risk, multiple variants with modest effects can add up to cause considerable variation in cancer risk in the general population. Identifying cancer risk genes can also indicate the underlying mechanisms of cancer growth. It is possible that we can develop new ways of preventing cancer as a result, similar to how we prevent heart disease and strokes by regular medication or lifestyle changes.1 Publication
| Pub ID | Title | Author(s) | Year | Journal |
|---|---|---|---|---|
| 20163 | Germline haploinsufficiency of MUTYH causes mutational signature SBS18 in multiple tumour types and specifically raises colorectal cancer risk | Kitty Sherwood (+10) | 2026 | npj Precision Oncology |
Enabling scientific discoveries that improve human health